Pulmonx Corporation
LUNG · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$56,394 | -$60,843 | -$58,923 | -$48,661 |
| Dep. & Amort. | $1,493 | $1,548 | $3,998 | $3,160 |
| Deferred Tax | $0 | $0 | $49 | -$6 |
| Stock-Based Comp. | $22,955 | $22,101 | $0 | $0 |
| Change in WC | -$1,703 | -$2,558 | -$7,063 | -$7,840 |
| Other Non-Cash | $2,112 | $2,142 | $16,803 | $11,918 |
| Operating Cash Flow | -$31,537 | -$37,610 | -$45,136 | -$41,429 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$1,447 | -$807 | -$1,318 | -$3,671 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | -$27,914 | -$46,200 | -$47,187 | -$52,584 |
| Inv. Sales/Matur. | $46,837 | $45,000 | $44,280 | $10,000 |
| Other Inv. Act. | $0 | $0 | $0 | $0 |
| Investing Cash Flow | $17,476 | -$2,007 | -$4,225 | -$46,255 |
| Financing Activities | – | – | – | – |
| Debt Repay. | -$95 | $19,906 | -$87 | $0 |
| Stock Issued | $0 | $0 | $2,586 | $4,523 |
| Stock Repurch. | $0 | $0 | -$27 | -$26 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $1,458 | $1,494 | $0 | $0 |
| Financing Cash Flow | $1,363 | $21,400 | $2,472 | $4,497 |
| Forex Effect | $76 | $34 | $145 | $106 |
| Net Chg. in Cash | -$12,622 | -$18,183 | -$46,744 | -$83,081 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $83,784 | $101,967 | $148,711 | $231,792 |
| End Cash | $71,162 | $83,784 | $101,967 | $148,711 |
| Free Cash Flow | -$32,984 | -$38,417 | -$46,454 | -$45,100 |